[Asia Economy Reporter Kwon Jae-hee]
▲ HLB = Decided on a 330 billion KRW rights offering
▲ Medytox = Q2 operating profit of 10.4 billion KRW... 134% increase YoY
▲ Kolon TissueGene = 39 billion KRW rights offering
▲ Suzen Tech = Q2 operating profit of 9.1 billion KRW... turned profitable
▲ Selvas AI = 2 billion KRW rights offering... allocated to Wysiwyg Studios
▲ Lunit = H1 sales of 5.5 billion KRW, up 291%... operating loss of 27.1 billion KRW
▲ Me2on = Q2 operating profit of 7.5 billion KRW... down 26.3% YoY
Hot Picks Today
![About 100 Trillion Won at Stake... "Samsung Strike Is an Unprecedented Opportunity" as Prices Surge 20% [Taiwan Chip Column]](https://cwcontent.asiae.co.kr/asiaresize/93/2026051416263163580_1778743590.jpg)
About 100 Trillion Won at Stake... "Samsung Strike Is an Unprecedented Opportunity" as Prices Surge 20% [Taiwan Chip Column]
- "Heading for 2 Million Won": The Company the Securities Industry Says Not to Doubt [Weekend Money]
- "Envious of Korean Daily Life"...Foreign Tourists Line Up in Central Myeongdong from Early Morning [Reportage]
- "Anyone Who Visited the Room Salon, Come Forward"… Gangnam Police Station Launches Full Staff Investigation After New Scandal
- Did Samsung and SK hynix Rise Too Much?... Foreign Assets Grow Despite Selling [Weekend Money]
▲ Seegene = Q2 operating profit of 13 billion KRW... down 91% YoY
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
